raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:723101

Clinical variant galactosemia

Type
Disease
Group
Disorder
Age of onset
Neonatal
Status
active

A form GALT deficiency characterized by residual GALT activity between 1-10% of control activity. Clinical features are similar to the patients presenting with classic galactosemia, including life threatening complications including feeding problems, failure to thrive, hepatocellular damage include cirrhosis and bleeding in untreated infants. With adequate and early treatment patients do not usually present risk for long-term complications, including premature ovarian insufficiency. Compared to classic galactosemia patients usually are not considered as having a high risk for developmental delay, speech and motor function abnormalities.

1

Names in Orphadata languages

9 of 12 languages
LangNameSynonyms
enClinical variant galactosemia
frGalactosémie variante clinique
deKlinische Variante der Galaktosämie
esGalactosemia variante clínica
itGalattosemia variante clinica
nlKlinische variant van galactosemie
ptClinical variant galactosemia
plClinical variant galactosemia
csClinical variant galactosemia
2

Cross-references

qualifier = Orphanet mapping relation

No cross-references in this release.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card